Coronavirus news recap
LexaGene CEO and Founder Dr. Jack Regan explains the threat of the current coronavirus outbreak and recaps LexaGene’s latest news describing the company’s role in preventing the spread of pathogens like coronavirus.
LexaGene featured on CBS Boston 4
LexaGene was featured on CBS Boston 4 WBZ during the news reporting of the EEE virus outbreak in Massachusetts
and other states.
Interview on EEE Testing
LexaGene CEO Dr. Jack Regan speaks to Proactive Investors explaining what LexaGene is doing to help respond to the rising threat of EEE Virus in Massachusetts and other states. Watch video.
LexaGene discusses ASL beta testing for Human Clinical
LexaGene CEO Dr. Jack Regan discusses beta testing client Assurance Scientific Laboratories (ASL) and their plans to use the LX Analyzer prototype in human clinical diagnostics. Watch video.
LexaGene discusses FDA AR Isolate Bank
LexaGene discusses recent approval by CDC and FDA Antibiotic Resistance Isolate Bank to receive samples for testing. Watch video.
Interview on filing three additional patents
LexaGene CEO Dr. Jack Regan discusses the recent filing of three additional patents and plans for the company. Watch video.
Beta Testimonial Video
Vets at Massachusetts Veterinary Referral Hospital describe how LexaGene’s beta prototype has excited them and given them a view of the future: rapid, in-clinic diagnostics that improve confidence in diagnosis, clinic workflow and patient outcome.
Interview on Antibiotic Resistance Panel
Dr. Jack Regan discusses LexaGene’s development of an antibiotic resistance panel to detect antibiotic resistance in pathogens in just one hour.
WCVB-TV Boston Feature
LexaGene was featured on ABC-affiliated television station WCVB Boston on a segment of ‘Cutting Edge’ on December 21, 2018. Watch now!
LexaGene HQ Tour
Take a short virtual tour of LexaGene and get an inside look at our state-of-the-art facilities.
LX2 Unveiling at AAVLD
LexaGene unveiled the LX2 prototype design to a veterinary diagnostics audience on October 20th, 2018 at the AAVLD Annual Meeting in Kansas City. LX2 Prototype design; Unveiling at Booth 203 by CEO Dr. Jack Regan; Veterinary diagnosticians engaging with LX2 technology.
LX Technical Overview Video
LexaGene describes the technology behind our fully automated, open-access pathogen detection device, the LX Analyzer.
12